actr3 (Proteintech)
Structured Review

Actr3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/actr3/product/Proteintech
Average 93 stars, based on 19 article reviews
Images
1) Product Images from "Expression of ACTR3 in cervical cancer and impact on immune cell infiltration and prognosis: A comprehensive analysis based on bulk RNA-Seq and single-cell RNA-Seq"
Article Title: Expression of ACTR3 in cervical cancer and impact on immune cell infiltration and prognosis: A comprehensive analysis based on bulk RNA-Seq and single-cell RNA-Seq
Journal: Medicine
doi: 10.1097/MD.0000000000046316
Figure Legend Snippet: The expression of ACTR3 is notably elevated in various cancers, including CESC. (A) The relationship between the expression levels of ACTR3 and OS in patients with various cancer types was assessed through univariate Cox regression analysis. (B) The radar chart depicts the expression levels of ACTR3 in tumor tissues. (C) A heatmap analysis was conducted to evaluate the correlation between the expression levels of ACTR3 and OS in patients with various cancer types. (D) The expression levels of ACTR3 in various human cancer tissues were analyzed in comparison to those in normal tissues, utilizing data sourced from the TCGA and GTEx databases. GTEx = genotype-tissue expression, OS = overall survival, TCGA = The Cancer Genome Atlas.
Techniques Used: Expressing, Comparison
Figure Legend Snippet: Expression of ACTR3-related genes and their prognostic significance. (A) A schematic representation illustrating the relationships among ACTR3 and several proteins obtained from the STRING database. (B) The forest plot illustrates the significance of genes associated with ACTR3 in terms of their predictive value. (C) The comparison of mRNA expression levels of ACTR3-related genes was conducted between normal tissues and tumor tissues.
Techniques Used: Expressing, Comparison
Figure Legend Snippet: Analysis of functional enrichment concerning DEGs predicated on the expression levels of ACTR3. (A–C) The GO enrichment analysis conducted on DEGs associated with ACTR3 identified significant enrichment in various biological processes, cellular components, and molecular functions. (D) An analysis of KEGG pathway enrichment pertaining to ACTR3 in CESC was conducted. (E–F) The grid chart presents the results obtained from the GO and KEGG analyses. CESC = cervical squamous cell carcinoma and endocervical adenocarcinoma, DEGs = differential expressed genes, GO = gene ontology, KEGG = Kyoto Encyclopedia of Genes and Genomes.
Techniques Used: Functional Assay, Expressing
Figure Legend Snippet: GSEA enrichment analysis of ACTR3. (A) The heat maps illustrate the ten genes that exhibit a positive co-expression relationship with ACTR3. (B) The heat maps illustrate the ten genes that exhibit a negative co-expression relationship with ACTR3. (C) The results obtained from GSEA are illustrated using mountain plots. (D–G) An examination of the functional roles and pathway enrichment related to ACTR3 is provided. GSEA = gene set enrichment analysis.
Techniques Used: Expressing, Functional Assay
Figure Legend Snippet: The examination of the relationship between the infiltration of immune cells and the expression levels of ACTR3. (A) Spearman correlation analysis was conducted to evaluate the relationship between the infiltration levels of 24 distinct immune cell types and the expression levels of ACTR3. (B–L) A scatter plot illustrating the extent of immune cell infiltration in relation to varying levels of ACTR3 expression. (M) A heatmap depicting the infiltration of immune cells corresponding to different levels of ACTR3 expression.
Techniques Used: Expressing
Figure Legend Snippet: The influence of ACTR3 expression on prognosis and its diagnostic significance. (A) The relationship between OS and the expression levels of ACTR3 across different clinical subgroups of CESC. (B) Proportion of mortality as risk score values escalated within low and high-risk groups. (C) Time-dependent survival ROC curves were generated to estimate the survival probabilities at 1-, 3-, and 5-yr intervals for patients diagnosed with CESC, utilizing the expression levels of ACTR3 as the predictive variable. (D) A nomogram was constructed to forecast the OS rates at 1, 3, and 5 yr for individuals diagnosed with CESC. CESC = cervical squamous cell carcinoma and endocervical adenocarcinoma, OS = overall survival, ROC = receiver operating characteristic.
Techniques Used: Expressing, Diagnostic Assay, Generated, Construct
Figure Legend Snippet: Association between ACTR3 expression and clinical features. (A–G) The correlation between ACTR3 expression and multiple clinical parameters – such as the T stage, N stage, M stage, OS events, DSS events, PFI events, and histological type – have been explored. (H–J) Calibration plots were generated to assess the accuracy of predictions for OS at 1-, 3-, and 5-yr intervals. (K) A nomogram has been developed to forecast the 1-, 3-, and 5-yr OS rates in patients diagnosed with CESC. CESC = cervical squamous cell carcinoma and endocervical adenocarcinoma, DSS = disease-specific survival, OS = overall survival, PFI = progression-free interval.
Techniques Used: Expressing, Generated
Figure Legend Snippet: Analysis of single-cell RNA sequencing data from CESC tissues. (A and B) The bar chart, together with the stacked bar chart, depicts the cellular quantities observed in both the control group and the tumor group. (C and D) The allocation of various cell types among the control and tumor groups. (E) The PCA, t-SNE, and UMAP techniques were employed to visualize the 18 unique cellular clusters. (F, G) The clusters received further annotation through the use of designated marker genes. (H) The UMAP visualization illustrates the expression levels of ACTR3 distributed among various cell clusters. (I) Violin plots illustrating the expression levels of ACTR3 across all recognized cell types. (J) The expression of ACTR3 across all recognized cell types. CESC = cervical squamous cell carcinoma and endocervical adenocarcinoma.
Techniques Used: RNA Sequencing, Control, Marker, Expressing
Figure Legend Snippet: Validation of ACTR3 expression in clinical specimens from patients diagnosed with CESC. (A) The protein expression levels of ACTR3, KI67, and CK7 were found to be significantly higher in CESC compared to those in normal tissue samples. (B) Statistical analysis of ACTR3, KI67, and CK7 positive cells. CESC = cervical squamous cell carcinoma and endocervical adenocarcinoma.
Techniques Used: Biomarker Discovery, Expressing